Indivior Pharmaceuticals Inc (INDV) valuation
Indivior Pharmaceuticals P/E ratio history
Indivior Pharmaceuticals trades at 9.9 times its earnings over the last twelve months and 7.9 times the earnings analysts expect over the next twelve.
| Fiscal year ended | Price | EPS | P/E |
|---|---|---|---|
| Dec 31, 2025 | $35.88 | $1.64 | 21.9 |
| Dec 31, 2024 | $12.43 | $0.05 | 248.6 |
| Dec 31, 2023 | $15.27 | -$0.94 | n/m |
| Dec 31, 2022 | $21.75 | -$0.32 | n/m |
| Dec 31, 2021 | $17.25 | — | n/m |
| Dec 31, 2020 | $7.33 | — | n/m |
n/m: not meaningful (a loss, or earnings close to zero). The daily P/E line is a chart indicator in the app.
Indivior Pharmaceuticals valuation against its peers
| Company | Market value | P/E | Forward P/E | Price / sales |
|---|---|---|---|---|
| Indivior PharmaceuticalsINDV | $4.17B | 9.9 | 7.9 | 3.0 |
| CorvelCRVL | $4.17B | 36.5 | — | 4.2 |
| Edgewise TherapeuticsEWTX | $4.18B | — | — | — |
| Icu MedicalICUI | $4.09B | 137.6 | 17.8 | 1.9 |
| Adaptive BiotechnologiesADPT | $4.26B | — | — | 13.8 |
| IrhythmIRTC | $4.05B | — | 137.3 | 4.9 |
| Integer HoldingsITGR | $4.30B | 42.2 | 18.9 | 2.4 |
| Livanova PlcLIVN | $4.34B | 23.3 | 17.5 | 3.0 |
| Arcutis BiotherapeuticsARQT | $4.01B | 145.8 | 36.4 | 8.6 |
| Peer median | 42.2 | 18.9 | 4.2 |
Reading these multiples
The P/E divides the share price by earnings per share over the last twelve months; the forward P/E divides it by the earnings analysts expect over the next twelve. Price to sales compares the company's market value with its revenue over the last twelve months. A multiple reads differently from one industry to the next, so the peer group above is the fairer comparison.
See also: INDV financials · INDV returns
No forecast, no recommendation. This page describes Indivior Pharmaceuticals Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.